Literature DB >> 23435354

Pro-inflammatory and pathogenic properties of Annexin-A1: the whole is greater than the sum of its parts.

Fulvio D'Acquisto1, Giuseppa Piras, Lorenza Rattazzi.   

Abstract

According to Aristotle, "The whole is greater than the sum of its parts" and yet, although a long time has passed still, we seem to struggle to accept this universal concept. Searching in the literature for the biological function of Annexin-A1, one would find a wealth of information on its homeostatic and protective anti-inflammatory effects. However, very little has been said on its emerging role in a wide variety of pathological conditions ranging from cancer to autoimmunity. In this commentary, we will focus our attention on this novel pro-inflammatory and pathogenic "dark side" of Annexin-A1. We will summarize our current understanding of the signaling pathways regulated by this protein and link it to clinical and experimental evidences. Finally we will discuss assets and limitations of Annexin-A1 therapeutic strategies. Most importantly, we hope that this commentary will provide scientific support to "controversial" findings one might encounter while studying this fascinating protein. Crown
Copyright © 2013. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23435354     DOI: 10.1016/j.bcp.2013.02.011

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection.

Authors:  Fanny Tzelepis; Mark Verway; Jamal Daoud; Joshua Gillard; Kimya Hassani-Ardakani; Jonathan Dunn; Jeffrey Downey; Marilena Elena Gentile; Joanna Jaworska; Anthony Michel Jean Sanchez; Yohann Nédélec; Hojatollah Vali; Maryam Tabrizian; Arnold Scott Kristof; Irah Luther King; Luis Bruno Barreiro; Maziar Divangahi
Journal:  J Clin Invest       Date:  2014-12-22       Impact factor: 14.808

2.  The role of annexin A1 in the modulation of the NLRP3 inflammasome.

Authors:  Izabela Galvão; Renan V H de Carvalho; Juliana P Vago; Alexandre L N Silva; Toniana G Carvalho; Maísa M Antunes; Fabiola M Ribeiro; Gustavo B Menezes; Dario S Zamboni; Lirlândia P Sousa; Mauro M Teixeira
Journal:  Immunology       Date:  2020-03-30       Impact factor: 7.397

3.  Macrophage migration inhibitory factor counter-regulates dexamethasone-induced annexin 1 expression and influences the release of eicosanoids in murine macrophages.

Authors:  Yu Sun; Yu Wang; Jia-Hui Li; Shi-Hui Zhu; Hong-Tai Tang; Zhao-Fan Xia
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

4.  Proteome from patients with metabolic syndrome is regulated by quantity and quality of dietary lipids.

Authors:  Oriol Alberto Rangel-Zúñiga; Antonio Camargo; Carmen Marin; Patricia Peña-Orihuela; Pablo Pérez-Martínez; Javier Delgado-Lista; Lorena González-Guardia; Elena M Yubero-Serrano; Francisco J Tinahones; María M Malagón; Francisco Pérez-Jiménez; Helen M Roche; José López-Miranda
Journal:  BMC Genomics       Date:  2015-07-08       Impact factor: 3.969

5.  Annexin A1 peptide and endothelial cell-conditioned medium modulate cervical tumorigenesis.

Authors:  Laila Toniol Cardin; Janesly Prates; Bianca Rodrigues da Cunha; Eloiza Helena Tajara; Sonia Maria Oliani; Flávia Cristina Rodrigues-Lisoni
Journal:  FEBS Open Bio       Date:  2019-03-05       Impact factor: 2.693

6.  Expression levels and prognostic values of annexins in liver cancer.

Authors:  Chunbo Zhuang; Pei Wang; Ting Sun; Lei Zheng; Liang Ming
Journal:  Oncol Lett       Date:  2019-10-30       Impact factor: 2.967

Review 7.  Therapeutic potential for targeting Annexin A1 in fibrotic diseases.

Authors:  Zhibin Yan; Xurui Cheng; Tao Wang; Xiangyu Hong; Gang Shao; Caiyun Fu
Journal:  Genes Dis       Date:  2022-06-18

Review 8.  Annexin-A1: The culprit or the solution?

Authors:  Lauren Kelly; Sarah McGrath; Lewis Rodgers; Kathryn McCall; Aysin Tulunay Virlan; Fiona Dempsey; Scott Crichton; Carl S Goodyear
Journal:  Immunology       Date:  2022-03-01       Impact factor: 7.215

9.  Identification of hub biomarkers and immune cell infiltration characteristics of polymyositis by bioinformatics analysis.

Authors:  Qi Jia; Rui-Jin-Lin Hao; Xiao-Jian Lu; Shu-Qing Sun; Jun-Jie Shao; Xing Su; Qing-Feng Huang
Journal:  Front Immunol       Date:  2022-09-26       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.